aid: averna-therapeutics
name: Averna Therapeutics
description: 'Averna Therapeutics is a genetic-medicine biotechnology company creating
  what it calls the last, great missing tool required to break through the most persistent
  barriers in genetic medicine. Backed by Insight Partners, the company was recognized
  as an Endpoints 11 Most Promising Biotech Company in 2025 and has presented at the
  44th Annual J.P. Morgan Healthcare Conference. As a therapeutics R&D company it does
  not currently publish any public developer program, API, SDK, or API documentation
  surface; this API Evangelist profile tracks it as a company identity record only.'
url: https://raw.githubusercontent.com/api-evangelist/averna-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- insight-partners
x-tier: stub
x-tier-reason: portfolio-lead
x-website: https://avernatx.com/
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
image: https://avernatx.com/wp-content/uploads/img-AboutUs.png
tags:
- Company
- Biotech Therapeutics
- Genetic Medicine
- Biotechnology
- Life Sciences
- Drug Development
apis: []
common:
- type: Website
  url: https://avernatx.com/
- type: Blog
  url: https://avernatx.com/#news
- type: PrivacyPolicy
  url: https://avernatx.com/privacy-policy/
- type: TermsOfService
  url: https://avernatx.com/terms-of-use/
- type: X-LinkedIn
  url: https://www.linkedin.com/company/avernatx
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence